By analyzing the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database, we found that alkaline ceramidase 3 (ACER3) is upregulated in livers of patients with NASH. The gene discussed is ACER3; the disease is metabolic dysfunction-associated steatohepatitis.